Do you want to read an article? Please log in or register.
Endoscopic, radiologic, and histologic healing with vedolizumab in patients with active Crohn's disease
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease
Gastroenterology.
Löwenberg M, Vermeire S, Mostafavi N, Hoentjen F, Franchimont D, Bossuyt P, Hindryckx P, Rispens T, de Vries A, Janneke van der Woude C, Berends S, Ambarus CA, Mathot R, Clasquin E, Baert F, D'Haens G
doi: 10.1053/j.gastro.2019.05.067.
Inflammatory Bowel Disease
Complete Endoscopic Healing Associated With Better Outcomes Than Partial Endoscopic Healing in Patients With Crohn's Disease
Clin Gastroenterol Hepatol.
Yzet C, Diouf M, Le Mouel JP, Brazier F, Turpin J, Loreau J, Dupas JL, Peyrin-Biroulet L, Fumery M
doi: 10.1016/j.cgh.2019.11.025.
Inflammatory Bowel Disease
Validation of the "German Inflammatory Bowel Disease Activity Index (GIBDI)": An Instrument for Patient-Based Disease Activity Assessment in Crohn's Disease and Ulcerative Colitis
Z Gastroenterol.
Hüppe A, Langbrandtner J, Häuser W, Raspe H, Bokemeyer B
doi: 10.1055/a-0605-4080.
Inflammatory Bowel Disease
Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease
BMC Gastroenterol.
E Penna FGC, Rosa RM, da Cunha PFS, de Souza SCS, de Abreu Ferrari ML
doi: 10.1186/s12876-020-1183-x.
Inflammatory Bowel Disease
Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease
Clin Gastroenterol Hepatol.
Bossuyt P, Dreesen E, Rimola J, Devuysere S, De Bruecker Y, Vanslembrouck R, Laurent V, Zappa M, Savoye-Collet C, Pariente B, Filippi J, Baert F, D'haens G, Laharie D, Peyrin-Biroulet L, Vermeire S, Tailorix study group.
doi: 10.1016/j.cgh.2020.04.052.
RECOMMENDED
Inflammatory Bowel Disease
Vedolizumab Efficacy, Safety, and Pharmacokinetics with Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients with Crohn's Disease or Ulcerative Colitis
★ 2
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
J Crohns Colitis.
Vermeire S, Lukáš M, Magro F, Adsul S, Lindner D, Rosario M, Roth J, Danese S
doi: 10.1093/ecco-jcc/jjaa027.
Inflammatory Bowel Disease
Comparison of MRI Activity Scoring Systems and Features for the Terminal Ileum in Patients With Crohn Disease
doi: 10.2214/AJR.18.19876.
Inflammatory Bowel Disease
Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn's Disease
Inflamm Bowel Dis.
Osterman MT, Gordon IO, Davis EM, Ciorba M, Glover SC, Abraham B, Khan F, Guo X, Yee EU, Allard FD, Claggett B, Shen B, Liu JJ
doi: 10.1093/ibd/izz222.
Inflammatory Bowel Disease
Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis
J Crohns Colitis.
Hart L, Chavannes M, Kherad O, Maedler C, Mourad N, Marcus V, Afif W, Bitton A, Lakatos PL, Brassard P, Bessissow T
doi: 10.1093/ecco-jcc/jjz107.